关注慢性阻塞性肺疾病患者流感疫苗接种问题  

Focus on influenza vaccination in patients with chronic obstructive pulmonary disease

作　　者：孙永昌[1] Sun Yongchang(Department of Respiratory and Critical Care Medicine,Peking University Third Hospital,Beijing 100191,China)

机构地区：[1]北京大学第三医院呼吸与危重症医学科,北京100191

出　　处：《中华结核和呼吸杂志》2022年第4期333-334,共2页Chinese Journal of Tuberculosis and Respiratory Diseases

摘　　要：流感疫苗接种可降低慢性阻塞性肺疾病(简称慢阻肺)患者需要住院的下呼吸道感染发生率,降低病死率,减少急性加重频次,因此专业指南均推荐所有慢阻肺患者均应接受流感疫苗接种,但目前普遍存在慢阻肺患者流感疫苗接种率不足的情况。新型冠状病毒疫苗的大规模接种有可能改变人们对疫苗接种的认识,医务人员应积极采取相应措施,提高慢阻肺患者流感疫苗接种率。Influenza vaccination has been shown to reduce lower airway infections requiring hospitalization,and reduce mortality and exacerbation frequency in patients with chronic obstructive pulmonary disease(COPD),and therefore is recommended for all COPD patients by guidelines.However,the coverage of influenza vaccination in Chinese COPD patients is far from satisfactory.The large-scale COVID-19 vaccination may have a positive impact on the attitude towards influenza vaccines,and healthcare professionals should take active measures to improve the rate of influenza vaccination in patients with COPD.

关 键 词：下呼吸道感染 流感疫苗接种 慢阻肺患者 慢性阻塞性肺疾病 医务人员 降低病死率 急性加重 大规模接种 

分 类 号：R186[医药卫生—流行病学]